Meridian Wealth Management LLC Buys Shares of 4,704 iShares Biotechnology ETF (NASDAQ:IBB)

Meridian Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, Holdings Channel reports. The firm bought 4,704 shares of the financial services provider’s stock, valued at approximately $685,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Raymond James Trust N.A. lifted its stake in shares of iShares Biotechnology ETF by 71.5% in the 3rd quarter. Raymond James Trust N.A. now owns 2,669 shares of the financial services provider’s stock valued at $389,000 after purchasing an additional 1,113 shares during the last quarter. Citizens Financial Group Inc. RI acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $288,000. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $29,000. Commerce Bank lifted its stake in shares of iShares Biotechnology ETF by 1.8% in the 3rd quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after purchasing an additional 12,921 shares during the last quarter. Finally, Avior Wealth Management LLC lifted its stake in shares of iShares Biotechnology ETF by 438.2% in the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock valued at $470,000 after purchasing an additional 2,629 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $137.96 on Monday. iShares Biotechnology ETF has a fifty-two week low of $117.28 and a fifty-two week high of $150.57. The firm has a fifty day moving average price of $143.43 and a two-hundred day moving average price of $141.87.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.